An Abbreviated Course of Therapeutic Plasma Exchange Does Not Affect Platelet Count Recovery or Durability in Patients With Immune Thrombotic Thrombocytopenic Purpura Receiving Caplacizumab

Documenti analoghi

• A Descriptive 5‐Year Analysis of the Demographics and Therapies for Patients With Immune Thrombotic Thrombocytopenic Purpura in the USA: A Multicenter Study of 390 Disease Episodes From 2017 to 2021
  di: Jeremy W. Jacobs, et al.
  Pubblicazione: (2025)
• Therapeutic Plasma Exchange to Reverse Plasma Failure in Multiple Organ Dysfunction Syndrome
  di: Matthew J. Foglia, et al.
  Pubblicazione: (2024)
• Bleeding Risk Is Not Increased When Initiating Therapeutic Plasma Exchange in Adults Using Exclusively Albumin Replacement Fluid 2 Days After Percutaneous Kidney Biopsy
  di: Jay S. Raval, et al.
  Pubblicazione: (2026)
• Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review
  di: Matthew H. Lanehart, et al.
  Pubblicazione: (2024)
• Variations in Therapeutic Plasma Exchange and Extracorporeal Photopheresis Practice Patterns: Survey Results From the ASFA Solid Organ Transplantation Subcommittee
  di: Grace M. Lee, et al.
  Pubblicazione: (2026)